The epidemiology of the oral lesions of HIV infection in the developed world (Q34775248)

4 August 2017

1 reference

title

The epidemiology of the oral lesions of HIV infection in the developed world (English)

1 reference

4 August 2017

0 references

1 reference

Greenspan JS

1

1 reference

PubMed ID

12164657

4 August 2017

Greenspan D

series ordinal

2

1 reference

4 August 2017

1 January 2002

1 reference

4 August 2017

1 reference

4 August 2017

8 Suppl 2

1 reference

4 August 2017

34-39

1 reference

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

4 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Evaluation of a clinical case-definition of acquired immunodeficiency syndrome in Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Seroconversion rate, mortality, and clinical manifestations associated with the receipt of a human immunodeficiency virus-infected blood transfusion in Kinshasa, Zaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

The accurate diagnosis of oral lesions in human immunodeficiency virus infection. Impact on medical staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Absence of Langerhans cells in oral hairy leukoplakia, an AIDS-associated lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Oral "hairy" leucoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Oral manifestations of HIV infection. Definitions, diagnostic criteria, and principles of therapy. The U.S.A. Oral AIDS Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Development of oral lesions in human immunodeficiency virus-infected transfusion recipients and hemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Tissue infiltration in a CD8 lymphocytosis syndrome associated with human immunodeficiency virus-1 infection has the phenotypic appearance of an antigenically driven response

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

A controlled trial of zidovudine in primary human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Predictors of mortality among HIV-infected women in Kigali, Rwanda

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Sarcoidosis in a patient with AIDS: a manifestation of immune restoration syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Oral candidiasis and immune status of HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Oral hairy leukoplakia and oral candidiasis as predictors of HIV viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

The prevalence of hairy leukoplakia in HIV seropositive and HIV seronegative immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Dental considerations for the paediatric AIDS/HIV patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

The Walter Reed staging classification for HTLV-III/LAV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Periodontal management of HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Outbreak of Burkitt's-like lymphoma in homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

Reduction of HIV-associated oral lesions after highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

Oral lesions as markers of severe immunosuppression in HIV-infected homosexual men and injection drug users

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

Immune recovery inflammatory folliculitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

Using serial observations to identify predictors of progression to aids in the Toronto Sexual Contact Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

Oral signs and symptoms in 160 Greek HIV‐infected patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

The association of clinical conditions and serologic tests with CD4 + lymphocyte counts in HIV-infected subjects without AIDS

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

Application of the World Health Organization system for HIV infection in a cohort of homosexual men in developing a prognostically meaningful staging system

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

Ability of primary care physicians to recognize physical findings associated with HIV infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

Morphology and membrane antigens of nonlymphoid accessory cells in oral hairy leukoplakia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

The natural history of HIV-1 infection: staging classifications of disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. European-Australian Acyclovir Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2002.00009.X

7 January 2021

10.1034/J.1601-0825.2002.00009.X

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12164657